scholarly journals Purpuric rash in an adolescent with fever, pancytopenia, and an hemophagocytic lymphohistiocytosis‐like syndrome due to parvovirus B19

2020 ◽  
Vol 8 (12) ◽  
pp. 3093-3097
Author(s):  
Maria Koliou ◽  
Anna Tryfonos ◽  
Myria Charalambous
2006 ◽  
Vol 47 (6) ◽  
pp. 861-861 ◽  
Author(s):  
Ş. Yılmaz ◽  
H. Ören ◽  
F. Demircioğlu ◽  
F. Fırıncı ◽  
A. Korkmaz ◽  
...  

2019 ◽  
Vol 7 (11) ◽  
pp. 2076-2081 ◽  
Author(s):  
James Kalmuk ◽  
Sara Matar ◽  
Gong Feng ◽  
Edward Kilb ◽  
Ming Y. Lim

2002 ◽  
Vol 35 (12) ◽  
pp. 1558-1561 ◽  
Author(s):  
Liora Harel ◽  
Ilan Straussberg ◽  
Abraham Zeharia ◽  
Dario Praiss ◽  
Jacob Amir

2014 ◽  
Vol 124 ◽  
pp. 438-441 ◽  
Author(s):  
Michinori Mayama ◽  
Masato Yoshihara ◽  
Tetsuya Kokabu ◽  
Hidenori Oguchi

2019 ◽  
Vol 7 ◽  
pp. 232470961988369
Author(s):  
Precious Macauley ◽  
Mohammad Abu-Hishmeh ◽  
Carissa Dumancas ◽  
Vijay Alexander-Rajan ◽  
Fernando Piedra-Chavez ◽  
...  

Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening condition characterized by widespread inflammation due to massive immune activation and cytokine release. It is of 2 types, primary or familial and secondary or acquired. Diagnosis is made by fulfilling 5 of 8 criteria as determined by the Histiocyte Society. Treatment includes etoposide, dexamethasone, with or without intrathecal methotrexate in the presence of neurologic involvement as well as treating the underlying cause in secondary HLH. We present a case of a 23-year-old female with congenital human immunodeficiency virus (HIV) infection who presents with nonspecific signs and symptoms of cough, fever, leukopenia, and anemia, and a high-serum parvovirus B19 DNA, later diagnosed with HLH and treated with etoposide and dexamethasone. She made clinical improvements and was successfully discharged to home after 26 days of admission.


Sign in / Sign up

Export Citation Format

Share Document